Figure 1 (Firazyr 01)
Firazyr Injection, Solution
Product Images NDC 54092-702
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Firazyr (NDC 54092-702). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2 (Firazyr 02)
Figure A (Firazyr 03)
This is a description of a prefilled syringe which has a needle cap seal.*
Figure B (Firazyr 04)
Figure C (Firazyr 05)
Figure D (Firazyr 06)
Figure E (Firazyr 07)
Figure F (Firazyr 08)
Figure G (Firazyr 09)
Figure H (Firazyr 10)
Figure I (Firazyr 11)
Figure J (Firazyr 12)
Figure K (Firazyr 13)
This text is a list of two angle measurements. It describes a 45 degree angle and a 90 degree angle.*
Figure L (Firazyr 14)
Figure M (Firazyr 15)
Figure N (Firazyr 16)
Figure O (Firazyr 17)
Principal Display Panel (3 mL Syringe Carton)
This is a description for Firazyr, which is a medication used for subcutaneous injections. It is distributed by A2 KetaMacect and contains icatibant. It comes in a 30mg pre-filled syringe and is for subcutaneous use only. The injection contains a go-to ingredient called hyaluronidase. The medication's packaging contains one pre-filled syringe and a 25G needle for injecting.*
Principal Display Panel (3 Syringe Carton)
This is a description of a subcutaneous injection medication called Firazyr. It comes in a pre-filled syringe with a capacity of 30 mg/3 mL. The syringe is closed with a protective cap and is for single-use only. The instruction indicates that any unused portion should be discarded. It also reveals that the medication has an active ingredient of icatibant and some other substances like sodium chiorce (sotonicity reagent) and glacal acetic acid. However, the medication is not described in detail, and the information provided may not be sufficient for use without the consultation of a qualified healthcare professional.*
Principal Display Panel (3 mL Syringe Carton)
This is a description of a medication called Firazyr. It is a pre-filled syringe for subcutaneous injection and each syringe contains 30mg of icatibant equivalent to 34.14mg of icatibant acetate. The medication is not for sale and the pack contains one syringe and a hypodermic needle. The medication should be stored between 2°C and 25°C, and discarded if it is unused. The packaging has a prescription information, dosage, and administration details for the patient.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
